Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment
E Gane, E Lawitz, D Pugatch… - … England Journal of …, 2017 - Mass Medical Soc
Background Chronic hepatitis C virus (HCV) infection is more prevalent among patients who
have chronic kidney disease than among those who do not have the disease. Patients with …
have chronic kidney disease than among those who do not have the disease. Patients with …
[引用][C] Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment
E Gane, C Moreno, M Colombo… - The New England …, 2017 - difusion.ulb.ac.be
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.
E Gane, E Lawitz, D Pugatch… - The New England …, 2017 - europepmc.org
Background Chronic hepatitis C virus (HCV) infection is more prevalent among patients who
have chronic kidney disease than among those who do not have the disease. Patients with …
have chronic kidney disease than among those who do not have the disease. Patients with …
Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment
E Gane, E Lawitz, D Pugatch… - NEW ENGLAND …, 2017 - iris.unisa.it
BACKGROUND: Chronic hepatitis C virus (HCV) infection is more prevalent among patients
who have chronic kidney disease than among those who do not have the disease. Patients …
who have chronic kidney disease than among those who do not have the disease. Patients …
Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment
E Gane, E Lawitz, D Pugatch… - … England Journal of …, 2017 - scholars.uthscsa.edu
BACKGROUND: Chronic hepatitis C virus (HCV) infection is more prevalent among patients
who have chronic kidney disease than among those who do not have the disease. Patients …
who have chronic kidney disease than among those who do not have the disease. Patients …
Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment.
E Gane, E Lawitz, D Pugatch, G Papatheodoridis… - 2017 - cabidigitallibrary.org
Background: Chronic hepatitis C virus (HCV) infection is more prevalent among patients
who have chronic kidney disease than among those who do not have the disease. Patients …
who have chronic kidney disease than among those who do not have the disease. Patients …
[引用][C] Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
E Gane, E Lawitz, D Pugatch… - New England Journal …, 2017 - cir.nii.ac.jp
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
E Gane, E Lawitz, D Pugatch… - The New England …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Chronic hepatitis C virus (HCV) infection is more prevalent among patients who
have chronic kidney disease than among those who do not have the disease. Patients with …
have chronic kidney disease than among those who do not have the disease. Patients with …
[PDF][PDF] Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
E Gane, E Lawitz, D Pugatch, G Papatheodoridis… - N Engl J Med, 2017 - natap.org
BACKGROUND Chronic hepatitis C virus (HCV) infection is more prevalent among patients
who have chronic kidney disease than among those who do not have the disease. Patients …
who have chronic kidney disease than among those who do not have the disease. Patients …
[PDF][PDF] Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
E Gane, E Lawitz, D Pugatch, G Papatheodoridis… - N Engl J Med, 2017 - natap.org
BACKGROUND Chronic hepatitis C virus (HCV) infection is more prevalent among patients
who have chronic kidney disease than among those who do not have the disease. Patients …
who have chronic kidney disease than among those who do not have the disease. Patients …